Responsibilities:
Cardio-vascular portfolio development: market trends analysis, products analysis, product assimilation capabilities, positioning and market potential, product registration according to the National Drug Agency rules and regulations, clinical studies, market specific and product-related trainings for the Medical Representatives team.
Product assimilation project through co-operation with Ethypharm (French pharmaceutical laboratory)
Brand planning, along with budgeting, marketing and communication strategy, forecasting and commercial policy for pre-launch, launch, re-launch and product follow-up through action plans dedicated to the whole product life cycle.
Medical Representatives team development according to cardio-vascular market standards, including specific training and coaching, performance evaluation.
Results:
Launch of several brand new product (i.e.: the hypolipemiant agent Lipofib SR, the vasodilating agent Pentoxi retard)
1st product portfolio to reach over 10MUSD (cardiovascular)
Reports to the Pharma Division Director and to Administrative Council of the Board.
Further information’s available on company website: www.terapia.ro; www.ethypharm-pharmaceutical.com/
No comments:
Post a Comment